“…However, because small molecules have less binding surface and are difficult to immobilize, application of the technology directly for small molecules can be challenging. A few studies have successfully employed peptide display to select binders for small molecules, for example, fluorophores [29], 2,4,6-trinitrotoluene [30], microcystin-LR [31], and paclitaxel (Taxol) [32]. We recently presented a panning strategy for the integrated selection of phage-borne peptides binding to either a particular ligand-antibody complex or a ligand-free antibody, leading to the development of assays for the targeted ligand 2,2 0 , 4,4 0 -tetrabromodiphenyl ether (BDE47) [33].…”